Overview
- 282 inspections across 260 sites are on record.
- 212 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-10-24.
At a glance
Inspections
282
Sites
260
Observations
212
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| John Brandsema, M.D. | 24 Oct 2024 | Human Drugs | |
| ALTASCIENCES PRECLINICAL SCRANTON INC. | 11 Oct 2024 | Human Drugs | |
| Janssen Biotech Inc. | 24 Sep 2024 | Human Drugs | |
| David Weisman, M.D. | 9 Sep 2024 | Human Drugs | View 483 → |
| Inotiv | 18 Jul 2024 | Human Drugs |
Sites inspected
John Brandsema, M.D.Philadelphia, United States1 insp.
ALTASCIENCES PRECLINICAL SCRANTON INC.Scott Township, United States1 insp.
Janssen Biotech Inc.Horsham, United States1 insp.
David Weisman, M.D.Abington, United States1 insp.
InotivRockville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sean D Duke18 shared
Michael J Mero11 shared
Brian D Young7 shared
Lauren N Shade7 shared
Michele M Falchek6 shared
Gerald W Kopp5 shared
Anastasia I Offordile4 shared
Gabrielle J Swain3 shared
Kelly N Kerr3 shared
Kyle S Hobson3 shared
Full investigator report
Get the verbatim findings behind Stephanie C Mangigian's 212 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site